#797 — The Industry Wire

April 29, 2026 Brian Casey 0 min read
  1. FDA launches “real-time clinical trials” for faster drug review.
  2. GLP-1 drug improves motivation in trial with depressed patients.
  3. New survey tracks rise in health system CEO pay. 
  4. Congressional hearing criticizes CEOs for high healthcare costs.
  5. OxyContin maker Purdue to dissolve as criminal trial concludes.
  6. Utah medical board wants to suspend AI prescription program.
  7. Nebraska first to implement Medicaid work mandates next month,
  8. Health companies jockey for share of $50B rural health fund.
  9. FDA testing confirms safety of infant formula. 
  10. CDC says backyard poultry may raise salmonella risk. 
Get every issue of The Imaging Wire, delivered right to your inbox.

You might also like

Artificial Intelligence May 28, 2026

Does AI Still Scare Off Radiology Trainees? May 28, 2026

Is AI still scaring off medical students from radiology as a specialty? Researchers asked them in a new study.

Imaging IT May 28, 2026

You’ve Gone Full Circle. Now Move Forward with Modern Reporting May 28, 2026

Say goodbye to PowerScribe 360. Microsoft is sunsetting the legacy platform by ending maintenance renewals in August 2026 and full support in 2027. Conveniently, they’re urging customers […]

Artificial Intelligence May 21, 2026

AI for Chest X-Ray Varies May 21, 2026

A new study found wide variation in performance for seven commercially available chest X-ray AI algorithms for detecting lung cancer.